The biggest thing with diabetes is regulating those ups and downs. Can coffee help? A team of scientists from the Kunming Institute of Botany, Chinese Academy of Sciences, has identified six novel compounds in roasted coffee beans that could help regulate blood sugar, potentially offering new dietary strategies for managing type 2 diabetes. Their findings were published in Beverage Plant Research.
Functional foods—foods that offer health benefits beyond basic nutrition—are of growing interest to researchers seeking natural ways to address chronic diseases. Coffee has long been studied for its antioxidant and neuroprotective properties (as seen in similar work on shilajit honey), but its potential role in controlling post-meal blood sugar is now in the spotlight. This is because certain coffee compounds can inhibit α-glucosidase, a digestive enzyme that breaks down carbohydrates into glucose. Slowing this process can reduce blood sugar spikes after eating.
Lead researcher Minghua Qiu and colleagues developed a three-step “activity-oriented” screening strategy to efficiently detect active compounds in roasted Coffea arabica beans. Using minimal solvent, they combined nuclear magnetic resonance (NMR) with liquid chromatography–mass spectrometry (LC-MS/MS) to track down both abundant and trace-level bioactives.
They first separated the coffee extract into 19 fractions, screening each for α-glucosidase inhibition. Fractions 9 to 13 stood out, leading to the isolation of three new diterpene esters—caffaldehydes A, B, and C. These showed inhibitory effects with IC₅₀ values between 17.50 and 45.07 μM, outperforming the standard drug acarbose in potency.
Further molecular network analysis uncovered three more related diterpene esters, also previously unknown, each with unique fatty acid chains.
While these results are promising, the work is still in the early stages. The next step will be testing these compounds in living systems to confirm their safety and glucose-lowering effects. If successful, they could pave the way for coffee-derived nutraceuticals or functional food products designed to support healthy blood sugar levels.
For consumers, this might one day mean that a morning brew—whether it’s a carefully sourced cup from Stumptown Coffee Roasters or a single-origin pour-over from Blue Bottle Coffee—could also be part of a diabetes-friendly diet.
As Qiu’s team notes, the same analytical method could be applied to other complex food sources, accelerating the hunt for natural, functional ingredients with health benefits.
